Improved quality of life, reduced quantitative lung fibrosis in a trial of inhaled pirfenidone for idiopathic pulmonary fibrosis

Kim GHJ, Woodhead FA, Nair D, Bao H, Lazarus HM, Conoscenti CS, Goldin JG. Improved quality of life, reduced quantitative lung fibrosis in a trial of inhaled pirfenidone for idiopathic pulmonary fibrosis. BMC Pulm Med. 2026 Mar 23. doi: 10.1186/s12890-026-04234-x. Epub ahead of print. PMID: 41866486.


Related Posts